Covetrus Brand Thyro-Tabs® Canine(Levothyroxine sodium tablets), USP
Covetrus Brand Thyro-Tabs Canine is indicated for replacement therapy for diminished thyroid function in dogs (canine hypothyroidism).
• First FDA approved canine T4 tablets
• First canine T4 brand to achieve a Higher USP tablet standard
• Offers 24-month dose stability
• Available in both 1,000-count and 120-count bottles
SKU# DESCRIPTION UOM PKG
072366 0.1mg 120 Count Bottle
072365 0.1mg 1,000 Count Bottle
072368 0.2mg 120 Count Bottle
072367 0.2mg 1,000 Count Bottle
072370 0.3mg 120 Count Bottle
072369 0.3mg 1,000 Count Bottle
072372 0.4mg 120 Count Bottle
072371 0.4mg 1,000 Count Bottle
072374 0.5mg 120 Count Bottle
072373 0.5mg 1,000 Count Bottle
072376 0.6mg 120 Count Bottle
072375 0.6mg 1,000 Count Bottle
072378 0.7mg 120 Count Bottle
072377 0.7mg 1,000 Count Bottle
072380 0.8mg 120 Count Bottle
072379 0.8mg 1,000 Count Bottle
072382 1.0mg 120 Count Bottle
072381 1.0mg 1,000 Count Bottle
CAUTION: Federal law restricts this drug to use by or on the order of a licensed veterinarian. CONTRAINDICATION: Do not use in dogs with thyrotoxicosis or uncorrected adrenal insufficiency. WARNINGS: In humans and rodents, excess in utero exposure to thyroid hormones is associated with hypothalamic-pituitary- thyroid axis dysfunction and morphological thyroid gland defects in the offspring. The safety of Thyro-Tabs Canine hasnot been evaluated in breeding, pregnant, or lactating dogs.
Quality & value delivered.
15 February 2021 | Product and Promotions Guide 855.724.3461 northamerica.covetrus.com
© 2020 Covetrus. All Rights Reserved. No copying without permission. Not responsible for typographical errors. Lit. No. 20CVB363 (12/2020)
